Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuzhi Hong

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Biomedicines|July 29, 2023
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial ActivityDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2022
A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascadeJie Zeng, Yuzhi Hong, Ningqiu Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2025
Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetaseMiaomiao Chen, Runbo Cui, Shouqiang Hong, et al.
Msphere|November 20, 2024
Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon sourceWeiwei Zhu, Miaomiao Chen, Xue Zhang, et al.
Biosensors & Bioelectronics|August 6, 2022
Single Escherichia coli bacteria detection using a chemiluminescence digital microwell array chipWenshuai Wu, Binh Thi Thanh Nguyen, Patricia Yang Liu, et al.
International Journal of Endocrinology|May 30, 2018
The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical TrialXiaotong Yu, Lipeng Xu, Qiang Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trialFengmei Lian, Guangwei Li, Xinyan Chen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Biomedicines|July 29, 2023
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial ActivityDongguang Fan, Bin Wang, Giovanni Stelitano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2022
A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascadeJie Zeng, Yuzhi Hong, Ningqiu Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2025
Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetaseMiaomiao Chen, Runbo Cui, Shouqiang Hong, et al.
Msphere|November 20, 2024
Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon sourceWeiwei Zhu, Miaomiao Chen, Xue Zhang, et al.
Biosensors & Bioelectronics|August 6, 2022
Single Escherichia coli bacteria detection using a chemiluminescence digital microwell array chipWenshuai Wu, Binh Thi Thanh Nguyen, Patricia Yang Liu, et al.
International Journal of Endocrinology|May 30, 2018
The Efficacy and Safety of the Chinese Herbal Formula, JTTZ, for the Treatment of Type 2 Diabetes with Obesity and Hyperlipidemia: A Multicenter Randomized, Positive-Controlled, Open-Label Clinical TrialXiaotong Yu, Lipeng Xu, Qiang Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trialFengmei Lian, Guangwei Li, Xinyan Chen, et al.
Pageof 5